title: Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP.
authors.forename: Monica
authors.initials: M
authors.lastname: Testoni
authors.forename: Ivo
authors.initials: I
authors.lastname: Kwee
authors.forename: Timothy C
authors.initials: TC
authors.lastname: Greiner
authors.forename: Santiago
authors.initials: S
authors.lastname: Montes-Moreno
authors.forename: Julie
authors.initials: J
authors.lastname: Vose
authors.forename: Wing C
authors.initials: WC
authors.lastname: Chan
authors.forename: Annalisa
authors.initials: A
authors.lastname: Chiappella
authors.forename: Luca
authors.initials: L
authors.lastname: Baldini
authors.forename: Andrés J M
authors.initials: AJ
authors.lastname: Ferreri
authors.forename: Gianluca
authors.initials: G
authors.lastname: Gaidano
authors.forename: Michael
authors.initials: M
authors.lastname: Mian
authors.forename: Emanuele
authors.initials: E
authors.lastname: Zucca
authors.forename: Francesco
authors.initials: F
authors.lastname: Bertoni
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D055028:Comparative Genomic Hybridization; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D016259:Genes, myc; D006801:Humans; D053208:Kaplan-Meier Estimate; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D000069283:Rituximab; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone